Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa

NCT01530659 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinitis Pigmentosa
Usher Syndrome Type 2
Usher Syndrome Type 3

Interventions

DRUG: NT-501
PROCEDURE: Sham

Sponsor

Neurotech Pharmaceuticals

Collaborators

[object Object]